ABVD or BEACOPP baseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)–Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial-Reference-Cited by-同舟云学术

ABVD or BEACOPP baseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)–Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial

Published:2017-08 Issue: Volume:81 Page:45-55
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Fermé Christophe,Thomas José^ORCID,Brice Pauline,Casasnovas Olivier,Vranovsky Andrej,Bologna Serge,Lugtenburg Pieternella J.,Bouabdallah Réda,Carde Patrice,Sebban Catherine,Eghbali Houchingue^ORCID,Salles Gilles,van Imhoff Gustaaf W.,Thyss Antoine,Noordijk Evert M.,Reman Oumédaly,Lybeert Marnix L.M.,Janvier Maud,Spina Michele,Audhuy Bruno,Raemaekers John M.M.,Delarue Richard,Anglaret Bruno,de Weerdt Okke,Marjanovic Zora,Tersteeg Robbert J.H.A.^ORCID,de Jong Daphne,Brière Josette,Henry-Amar Michel^ORCID

Funder

EORTC Charitable Trust

Ministry of Health, Programme Hospitalier de Recherche Clinique

French National League Against Cancer

French Federation of Comprehensive Cancer centres (FNCLCC)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial;Engert;J Clin Oncol,2007

2. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease;Fermé;N Engl J Med,2007